![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » GENENTECH SHARES FALL ON FDA REQUEST FOR MORE AVASTIN INFO
GENENTECH SHARES FALL ON FDA REQUEST FOR MORE AVASTIN INFO
Genentech Inc. shares lost almost 5% Monday after the Food and Drug Administration said it needs more information to consider approving the biotechnology company's oncology drug Avastin as a treatment for advanced breast cancer.
Easy
Bourse
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct